Stroke disorder
Therapeutic area
Neurology
Rare disease
No
- Definition
- A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Stroke disorder
- Therapeutic area
- Neurology
- stroke disorder
- CVA
- CVA, cerebrovascular accident
- cerebrovascular accident
- cerebrovascular accident, (CVA)
- stroke
- stroke syndrome
- syndrome, stroke
- undetermined stroke
- Severity
- Severe
- Cardiology
- Neurology
- Vascular Medicine
- MONDO ID
- MONDO:0005098
- Parent condition
- MONDO:0011057
Related records
Broader conditions (10)
- Brain disorder
- Cardiovascular disorder
- Central nervous system disorder
- Cerebrovascular disorder
- Disease
- Disease by body system or component
- Human disease
- Nervous system disorder
- Neurovascular disorder
- Vascular disorder
Narrower conditions (19)
- Acquired aneurysmal subarachnoid hemorrhage
- Anterior cerebral artery infarction
- Anterior spinal artery stroke
- Brain stem infarction
- Cerebral infarction
- Hemorrhagic stroke
- Intracerebral hemorrhage
- Intracranial embolism
- Ischemic stroke
- Large artery stroke
- Lateral medullary syndrome
- Middle cerebral artery infarction
- Multi-infarct dementia
- Pediatric arterial ischemic stroke
- Posterior cerebral artery infarction
- Spinal cord ischemia
- Subarachnoid hemorrhage
- Transient ischemic attack
- Vertebral artery insufficiency
Trials (7,760)
- :Effects of Pharmaceutical Care in Stroke Patients
- 'Smart Reminder': a Feasibility Pilot Study on the Effects of a Wearable Device Treatment
- 'Smart Reminder': a Randomized Controlled Trial on the Effect of a Wearable Device
- "Bilateral Training in Stroke Patients"
- "Carotid Web Incidence and Radiological Classification, Determination of Its Relationship With Ischemic Stroke"
- "COMBO-KEY" - A Home Visiting and Phone Coaching Programme to Promote Stroke Survivors' Recovery
- "Comparison of Therapist-Led and Robot-Assisted Arm Therapy in Subacute Stroke Rehabilitation"
- "Core Stability" Exercises to Improve Sitting Balance in Stroke Patients
- "Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)"
- "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"
- "Evaluation Of ALBA® Device for Upper Extremity Motor Function In Adults With Subacute And Chronic Acquired Brain Injury"
- "GOLIATH" - General Or Local Anaestesia in Intra Arterial THerapy
- "Mobile Stroke Unit"-Concept for Delivery of Specialized Acute Stroke Care to Patients in Remote Areas
- "Mobile Stroke-Unit" for Reduction of the Response Time in Ischemic Stroke
- "Reliability of Motricity Index Strength Assessments for Upper Extremity in Post Stroke Hemiparesis- a Correlation Study''
- "Remind-to-move" for Promoting Upper Extremity Recovery in Patients With Stroke After Subacute Discharge
- "Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy
- "VRTierOne" as a Method Supporting the Post-stroke Rehabilitation
- [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease
- 1-year Clinical Outcomes in Recombinant Tissue Plasminogen Activator (Rt-PA) Treated Chinese Acute Ischaemic Stroke (AIS) Patients
Approved drugs (41)
- Aliskiren fumarate
- Alteplase
- Amlodipine besylate
- Apixaban
- Aspirin
- Atenolol
- Atorvastatin calcium
- Azilsartan kamedoxomil
- Benazepril hydrochloride
- Candesartan cilexetil
- Celecoxib
- Clopidogrel besilate
- Clopidogrel bisulfate
- Clopidogrel hydrobromide
- Clopidogrel hydrochloride
- Dabigatran etexilate mesylate
- Dantrolene sodium
- Dipyridamole
- Edoxaban tosylate
- Eplerenone
Drugs in development (142)
- Abciximab Phase 3
- Acetazolamide Phase 2
- Acetylcysteine Phase 2
- Amantadine Phase 2
- Amelparib dihydrochloride dihydrate Phase 1
- Armodafinil Phase 2
- Arundic acid Phase 2
- Atorvastatin Phase 2
- Basmisanil Phase 2
- Capsaicin Phase 1
- Carbidopa Phase 3
- Cilostazol Phase 2
- Citalopram Phase 3
- Citicoline Phase 3
- Clevidipine Phase 3
- Clomethiazole Phase 3
- Clopidogrel Phase 3
- Colchicine Phase 3
- Cromolyn Phase 3
- Cycloserine Phase 2
Other linked drugs (10)
- Bendroflumethiazide
- Botulinum toxin type A
- Chlorthalidone
- Hydrochlorothiazide
- Methylphenidate
- Midodrine
- Ranitidine
- Ticlopidine
- Tizanidine
- Zoledronic acid